SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

12 Aug 2022 Evaluate
The sales is pegged at Rs. 709.54 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 782.12 millions during the year-ago period.The Net Profit of the company slipped to Rs. 36.64 millions from Rs. 120.57 millions, a decline of -69.61% on QoQ basis.Operating Profit reported a sharp decline to 63.42 millions from 172.91 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 709.54 782.12 -9.28 709.54 782.12 -9.28 4058.42 3328.44 21.93
Other Income 30.12 27.39 9.97 30.12 27.39 9.97 153.83 113.20 35.89
PBIDT 63.42 172.91 -63.32 63.42 172.91 -63.32 948.56 860.73 10.20
Interest 0.24 0.85 -71.76 0.24 0.85 -71.76 4.85 5.00 -3.00
PBDT 63.18 172.06 -63.28 63.18 172.06 -63.28 943.71 855.73 10.28
Depreciation 10.67 9.20 15.98 10.67 9.20 15.98 37.95 36.70 3.41
PBT 52.51 162.86 -67.76 52.51 162.86 -67.76 905.76 819.03 10.59
TAX 15.87 42.29 -62.47 15.87 42.29 -62.47 233.88 207.14 12.91
Deferred Tax -1.74 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 36.64 120.57 -69.61 36.64 120.57 -69.61 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 8.94 22.11 -59.57 8.94 22.11 -59.57 23.37 25.86 -9.62

Amrutanjan Healthcar Share Price

546.50 7.85 (1.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×